 |
| Robin Pomeranz Cronin, Ivan Ruiz |
Finn Partners has added Robin Pomeranz Cronin as creative director and Ivan Ruiz as partner, global digital health to its healthcare practice.
Cronin was VP at Ogilvy PR’s creative studio and most recently served as head of creative at Syneos Health.
She has worked for clients such as Novartis, Pfizer, GSK and Sanofi in the areas of corporate rebrands, disease awareness and internal PR.
Ruiz joins Finn from Goodfuse Communications, where he was SVP, Innovation Studio working on social and digital marketing campaigns for pharmaceutical and biotech companies.
Previously, Ruiz was director of integrated marketing at Burson-Marsteller and digital strategist at Ogilvy Commonwealth Worldwide.
Cronin reports to Matt Bostrom, managing partner. Ruiz reports to Ritesh Patel, senior partner, global digital health.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
